Conducting collaborative research locally, nationally and globally.
Robert Kleinman 2024
Fentanyl, carfentanil and other fentanyl analogues in Canada’s illicit opioid supply: A cross-sectional studyRobert KleinmanDespite the increase in fentanyl-involved overdose deaths in Canada, there have been no national-level studies evaluating the… |
High-Dose Buprenorphine Initiation: A Scoping ReviewStanley Wong, Nicholas Fabiano, Declan Webber, Robert KleinmanHigh-dose buprenorphine initiation has not been associated with reported cases of overdose or respiratory depression. However, the current literature about high-dose buprenorphine is limited by… |
https://link.springer.com/article/10.1007/s11606-024-08642-9 |
Characteristics, Treatment Patterns and Retention with Extended-Release Subcutaneous Buprenorphine for Opioid Use Disorder: A Population-Based Cohort Study in Ontario, Canada.Anita Iacono, Tianru Wang, Mina Tadrous, Tonya Campbell, Gillian Kolla, Pamela Leece, Beth Sproule, Robert Kleinman…Uptake and retention for opioid agonist treatment (OAT) remains low. Novel extended-release formulations may improve OAT accessibility by reducing the frequency of healthcare visits. Our aim was to examine uptake, characteristics, treatment patterns and retention of individuals… |
The Institute for Mental Health Policy Research
Centre for Addiction and Mental Health
33 Ursula Franklin Street (Ursula Franklin and Spadina)
Toronto ON - M5S 2S1